336 related articles for article (PubMed ID: 12378627)
21. 5-fluorouracil mediates apoptosis and G1/S arrest in laryngeal squamous cell carcinoma via a p53-independent pathway.
Liu HC; Chen GG; Vlantis AC; Leung BC; Tong MC; van Hasselt CA
Cancer J; 2006; 12(6):482-93. PubMed ID: 17207318
[TBL] [Abstract][Full Text] [Related]
22. Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.
Kemeny N; Israel K; Niedzwiecki D; Chapman D; Botet J; Minsky B; Vinciguerra V; Rosenbluth R; Bosselli B; Cochran C
J Clin Oncol; 1990 Feb; 8(2):313-8. PubMed ID: 2405107
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
24. In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: timing of cisplatin treatment.
Cho H; Imada T; Oshima T; Shiozawa M; Rino Y; Takanashi Y
Gastric Cancer; 2002; 5(1):43-6. PubMed ID: 12021859
[TBL] [Abstract][Full Text] [Related]
25. [Knock-down of apollon gene by antisense oligodeoxynucleotide inhibits the proliferation of Lovo cells and enhances chemo-sensitivity].
He JH; Zhang XY; Wu FY; Liao XL; Wang W; Jiang JW
Yao Xue Xue Bao; 2011 Feb; 46(2):138-45. PubMed ID: 21542283
[TBL] [Abstract][Full Text] [Related]
26. Thioredoxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M phase arrest.
Fu JN; Li J; Tan Q; Yin HW; Xiong K; Wang TY; Ren XY; Zeng HH
Invest New Drugs; 2011 Aug; 29(4):627-36. PubMed ID: 20195699
[TBL] [Abstract][Full Text] [Related]
27. Synergistic antitumor effect of TRAIL and doxorubicin on colon cancer cell line SW480.
Xu LH; Deng CS; Zhu YQ; Liu SQ; Liu DZ
World J Gastroenterol; 2003 Jun; 9(6):1241-5. PubMed ID: 12800232
[TBL] [Abstract][Full Text] [Related]
28. Transplatin, a cisplatin trans-isomer, may enhance the anticancer effect of 5-fluorouracil.
Nakata B; Yamagata S; Kanehara I; Shirasaka T; Hirakawa K
J Exp Clin Cancer Res; 2006 Jun; 25(2):195-200. PubMed ID: 16918130
[TBL] [Abstract][Full Text] [Related]
29. Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in a colon cancer cell line.
Inoue Y; Miki C; Watanabe H; Hiro J; Toiyama Y; Ojima E; Yanagi H; Kusunoki M
J Gastroenterol; 2006 Dec; 41(12):1149-57. PubMed ID: 17287894
[TBL] [Abstract][Full Text] [Related]
30. G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity.
Mirjolet JF; Didelot C; Barberi-Heyob M; Merlin JL
Cytometry; 2002 May; 48(1):6-13. PubMed ID: 12116375
[TBL] [Abstract][Full Text] [Related]
31. Effects of cisplatin, 5-fluorouracil, and radiation on cell cycle regulation and apoptosis in the hypopharyngeal carcinoma cell line.
Lee BJ; Chon KM; Kim YS; An WG; Roh HJ; Goh EK; Wang SG
Chemotherapy; 2005 May; 51(2-3):103-10. PubMed ID: 15886465
[TBL] [Abstract][Full Text] [Related]
32. Chemoimmunosensitization of the T24 human bladder cancer line to Fas-mediated cytotoxicity and apoptosis by cisplatin and 5-fluorouracil.
Mizutani Y; Wu XX; Yoshida O; Shirasaka T; Bonavida B
Oncol Rep; 1999; 6(5):979-82. PubMed ID: 10425290
[TBL] [Abstract][Full Text] [Related]
33. Chloroquine enhances the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle alteration.
Choi JH; Yoon JS; Won YW; Park BB; Lee YY
APMIS; 2012 Jul; 120(7):597-604. PubMed ID: 22716215
[TBL] [Abstract][Full Text] [Related]
34. Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Melioli GG; Rosso R; Bertino JR
J Natl Cancer Inst; 1993 Dec; 85(23):1937-44. PubMed ID: 8230285
[TBL] [Abstract][Full Text] [Related]
35. Differential growth inhibition by 5-fluorouracil in human colorectal carcinoma cell lines.
Tokunaga E; Oda S; Fukushima M; Maehara Y; Sugimachi K
Eur J Cancer; 2000 Oct; 36(15):1998-2006. PubMed ID: 11000583
[TBL] [Abstract][Full Text] [Related]
36. Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.
Etienne MC; Bernard S; Fischel JL; Formento P; Gioanni J; Santini J; Demard F; Schneider M; Milano G
Br J Cancer; 1991 Mar; 63(3):372-7. PubMed ID: 2003979
[TBL] [Abstract][Full Text] [Related]
37. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
[TBL] [Abstract][Full Text] [Related]
38. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells.
Lim YJ; Rhee JC; Bae YM; Chun WJ
World J Gastroenterol; 2007 Apr; 13(13):1947-52. PubMed ID: 17461495
[TBL] [Abstract][Full Text] [Related]
39. Cyclin A correlates with the sensitivity of human cancer cells to cytotoxic effects of 5-FU.
Kawashima R; Haisa M; Kimura M; Takaoka M; Shirakawa Y; Takeda H; Uetsuka H; Gunduz M; Nagai N; Tanaka N; Naomoto Y
Int J Oncol; 2004 Feb; 24(2):273-8. PubMed ID: 14719102
[TBL] [Abstract][Full Text] [Related]
40. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
